Latest News and Events
Filter by
Selections
December 18, 2012
Arrowhead and Shire Enter into Collaboration and License Agreement to Develop Peptide-Targeted Therapeutics
Read MoreDecember 14, 2012
Arrowhead to Report Fiscal 2012 Fourth Quarter and Year-End Financial Results
Read MoreDecember 7, 2012
Arrowhead Announces Pricing of a Public Offering of Common Stock and Warrants
Read MoreNovember 27, 2012
Arrowhead Publishes First Ever Cholesterol-siRNA Mediated Gene Knockdown in Primates and Novel DPC Co-Injection Strategy
Read MoreNovember 13, 2012
Arrowhead Creates Hepatitis B Clinical Advisory Board and Names Dr. Robert Gish Chairman
Read MoreOctober 29, 2012
Arrowhead Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System
Read MoreOctober 16, 2012
Arrowhead Research Receives Notice of Patent Allowance for New Formulation of DPC siRNA Delivery System Showing 500-Fold Increase in Potency
Read MoreSeptember 5, 2012